Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

159.71 -0.55 (-0.34%)
Streaming Delayed Price Updated: 1:29 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
69 70 Next >
3 Must-Buy Blue-Chip Stocks if the Market Retests 2022 Lows
Believe it or not, Nvidia is one of our blue-chip stocks to buy. It has worked in the past and I suspect it will work again in the future. 
Via InvestorPlace
Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Increases Dividend: What Shareholders Need To Know
Johnson & Johnson recently raised its dividend by 5%, and thus it has now raised its dividend for 61 consecutive years. 
Via Talk Markets
KVUE Stock: Should You Buy Into the Kenvue IPO?
KVUE stock will be a dividend stock with an initial yield of 3.5%, with slow growth and lower margins than JNJ's drug business. 
Via InvestorPlace
2 Stocks to Buy With $200 That Can Survive Any Recession
These businesses have an excellent track record of surviving difficult economic times. 
Via The Motley Fool
Looking At Johnson & Johnson's Recent Unusual Options Activity
 
Via Benzinga
Artificial Intelligence Engine Predicts TCMD Stock to Gain 5.6% by May 30
Watch our new video to find out how you can get 3,000 more predictions just like this 
Via InvestorPlace
Artificial Intelligence Engine Predicts HUYA Stock to Gain 6.4% by May 30
Watch our new video to find out how you can get 3,000 more predictions just like this 
Via InvestorPlace
Artificial Intelligence Engine Predicts LYTS Stock to Gain 9% by May 30
Watch our new video to find out how you can get 3,000 more predictions just like this 
Via InvestorPlace
How Long Could It Take for Johnson & Johnson's Dividend Yield to Get to 5%?
Over time, your dividend payments from the stock are likely to rise significantly. 
Via The Motley Fool
Johnson & Johnson Ignites CAR-T Ambitions With Licensing Pact With Cellular Biomedicine
Johnson & Johnson's (NYSE: JNJ) pharma unit Janssen  
Via Benzinga
2 Incredibly Cheap Dividend Stocks to Buy in May
These two dividend-paying pharma stocks both screen as significantly undervalued right now. 
Via The Motley Fool
Better Growth Stock: Johnson & Johnson vs. Intuitive Surgical
Both are great companies, but one might be a slightly better option. 
Via The Motley Fool
EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations
The American Medical Association (AMA) is expected to issue the first code for psychedelic therapy reimbursement, following Tuesday's approval of a joint application submitted by MAPS PBC and COMPASS... 
Via Benzinga
The 7 Best Dividend Stocks to Buy for May 2023
Each of these seven dividend stocks to buy has a solid dividend yield, a sustainable payout ratio, and a history of dividend growth. 
Via InvestorPlace
KVUE Stock IPO: When Does Kenvue Go Public? What Is the Kenvue IPO Price Range?
Johnson & Johnson spinoff Kenvue is gearing up to go public on May 4. Here's what investors need to know about KVUE stock and the Kenvue IPO. 
Via InvestorPlace
If I Could Buy Only 1 Warren Buffett Stock in May, This Would Be It
Buffett would probably agree with this choice. 
Via The Motley Fool
7 High-Yield Dividend Stocks to Buy and Hold Forever
A stagnant market can be frustrating, but also a good time to look for high-yield dividend stocks to buy now. 
Via InvestorPlace
2 Simple Ways to Make $40,000 in Passive Income
Make your money work for you with these two investment options. 
Via The Motley Fool
Here Are The Best Sector ETFs And Major Sector-Moving Stocks In April
As April draws to a close, it's the right time to look back at how the 11 S&P 500 sector ETFs fared over the month. The market as a whole was only slightly positive for the month, with the SPDR S&P 500... 
Via Benzinga
Is It Too Late to Buy Johnson & Johnson's Stock?
This healthcare juggernaut's recent quarterly results prove just how strong its business is. 
Via The Motley Fool
Could Government Drug-Price Negotiations Sound The Death Knell For Biotech Stocks?
Experts fear a change in how Medicare buys drugs could slam biotech and pharma companies. 
Via Investor's Business Daily
3 Long-Term Stocks to Buy and Hold Forever
When it comes to stocks to buy and hold forever, investors have to make sure that the business will be around for the long term. 
Via InvestorPlace
The Fed Forecasts a Recession: 2 Top Warren Buffett Stocks to Buy Now
These two stocks will bring you passive income and growth over time. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
The Shake-Up at NBCUniversal and Johnson & Johnson's Spinoff Plans
Plus, "Doomberg" talks about Tesla. 
Via The Motley Fool
2 High-Yielding Dividend Stocks That Just Boosted Their Payouts
These are ideal stocks for long-term investors who crave dividends. 
Via The Motley Fool
The Fed Expects a Recession: 2 Dow Stocks to Buy Hand Over Fist and 1 to Avoid Like the Plague
Two time-tested Dow stocks are perfectly positioned if the U.S. dips into a recession, while another Dow component has an abysmal track record during economic downturns. 
Via The Motley Fool
Get Defensive with These 3 Cash Flow Producing Machines
Long-term investors are generally served well by considering companies with strong cash flow, and these are three of the best. 
Via InvestorPlace
7 Stocks That Are Strong Buys on the Heels of Impressive Earnings
Investors looking for strong buys in this market may want to consider companies that reported strong earnings recently. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
69 70 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.